BMS-345541 Hydrochloride: Selective IKK/NF-κB Pathway Inhibitor for Cancer and Inflammation Research

Executive Summary: BMS-345541 hydrochloride (SKU A3248) is a potent, selective allosteric inhibitor of IκB kinase (IKK) isoforms IKK-1 and IKK-2, with IC₅₀ values of 4 μM and 0.3 μM, respectively (APExBIO). The compound blocks NF-κB-dependent transcription and downstream pro-inflammatory cytokine production in vitro and in vivo (Du et al., 2021). It is highly water-soluble (≥60 mg/mL), stable at -20°C, and orally bioavailable in animal models. BMS-345541 hydrochloride induces apoptosis and G2/M phase arrest in T-ALL cell lines, highlighting its translational relevance in cancer biology (Peptone-Bacteriological). Its selectivity eliminates off-target effects on other kinases, ensuring robust, reproducible results for NF-κB pathway research.

Biological Rationale

The IKK/NF-κB axis is a central regulator of inflammatory and cell death pathways. Activation of IKK (comprising IKK-1/IKKα, IKK-2/IKKβ, and NEMO) leads to phosphorylation and degradation of IκB, liberating NF-κB to drive expression of genes involved in immune response, apoptosis, and cell survival (Du et al., 2021). Dysregulation is implicated in numerous diseases, including autoimmune disorders, inflammation, and cancer. In T-cell acute lymphoblastic leukemia (T-ALL), constitutive NF-κB activation confers resistance to chemotherapy and promotes survival (Peptone-Bacteriological, 2023). Selective inhibition of IKK enzymes is thus a precise strategy to modulate these pathways for both fundamental research and potential therapeutic intervention.

Mechanism of Action of BMS-345541 hydrochloride

BMS-345541 hydrochloride acts as an allosteric inhibitor, binding to a unique site on IKK-1 and IKK-2 that does not overlap with the ATP-binding site. This results in potent inhibition of IKK catalytic activity (IC₅₀: 4 μM for IKK-1, 0.3 μM for IKK-2) (APExBIO). The compound does not inhibit other serine/threonine or tyrosine kinases at comparable concentrations, demonstrating high selectivity. BMS-345541 hydrochloride blocks stimulus-induced phosphorylation of IκB, thereby preventing NF-κB nuclear translocation and subsequent transcription of TNFα, IL-1β, IL-6, and IL-8 (Du et al., 2021). Importantly, it does not interfere with upstream signaling components or parallel signaling cascades, preserving pathway specificity (5-Formyl-CTP).

Evidence & Benchmarks

• BMS-345541 hydrochloride inhibits IKK-2 with an IC₅₀ of 0.3 μM and IKK-1 with an IC₅₀ of 4 μM, as measured in kinase assays (APExBIO).
• NF-κB-dependent transcription of TNFα, IL-1β, IL-6, and IL-8 is dose-dependently inhibited in both in vitro and in vivo models (Du et al., 2021).
• BMS-345541 hydrochloride is inactive against a panel of 21 other serine/threonine and tyrosine kinases at concentrations up to 100 μM (Peptone-Bacteriological, 2023).
• In T-ALL cell lines, BMS-345541 hydrochloride induces apoptosis and G2/M cell cycle arrest, overcoming chemotherapeutic resistance (Peptone-Bacteriological, 2023).
• Oral administration in animal models yields 100% bioavailability and robust TNFα inhibition in plasma assays (APExBIO).
• The compound is soluble in water at ≥60 mg/mL, but insoluble in ethanol and DMSO; stock solutions stable for several months at -20°C (APExBIO).

Applications, Limits & Misconceptions

BMS-345541 hydrochloride is a cornerstone reagent for:

• Dissecting the IKK/NF-κB signaling pathway in cell death, inflammation, and immunity research (Peptone-Bacteriological, 2023).
• Studying pro-inflammatory cytokine regulation and the resolution of inflammation (5-Formyl-CTP).
• Modeling and overcoming chemoresistance in T-ALL and other NF-κB-driven cancers.
• Validating selectivity in kinase profiling and cell-based assays, avoiding confounding off-target effects.

This article extends previous coverage by providing structured, machine-readable benchmarks and a specific focus on the boundaries of BMS-345541 hydrochloride's activity, contrasting with Peptone-Bacteriological (2023), which emphasizes practical workflow integration. For an advanced mechanistic perspective on NF-κB axis disruption, see Strategic Disruption of the IKK/NF-κB Axis; this article provides updated application parameters and clarifies selectivity benchmarks.

Common Pitfalls or Misconceptions

• BMS-345541 hydrochloride is not an ATP-competitive inhibitor: It binds allosterically and will not compete with ATP analogs in assays (APExBIO).
• The compound is not effective in ethanol or DMSO: Solubility is limited to water; improper solvent use leads to precipitation or loss of activity.
• It does not inhibit other kinases: Kinase panel assays confirm selectivity; do not attribute broad-spectrum kinase inhibition to BMS-345541 hydrochloride (Peptone-Bacteriological, 2023).
• Long-term solution storage reduces efficacy: Prepare solutions freshly or store at -20°C for limited periods as recommended.
• NF-κB-independent cell death is not targeted: BMS-345541 hydrochloride specifically modulates IKK/NF-κB-dependent pathways and is not effective in NF-κB-independent apoptosis or necroptosis models (Du et al., 2021).

Workflow Integration & Parameters

Solubility and Handling: Dissolve BMS-345541 hydrochloride in sterile water at concentrations up to 60 mg/mL. Avoid ethanol and DMSO. Store stock solutions at -20°C; use within several months for optimal activity (APExBIO).

Recommended Concentrations: For in vitro cell assays, typical working concentrations range from 0.1 μM to 10 μM. For animal studies, oral dosing achieves full bioavailability. Assay-specific optimization is advised.

Controls: Use vehicle-only and unrelated kinase inhibitor controls to validate selectivity.

For detailed laboratory scenarios and troubleshooting, see BMS-345541 Hydrochloride (SKU A3248): Evidence-Based IKK ...; this article provides additional parameterization for advanced users.

Conclusion & Outlook

BMS-345541 hydrochloride, distributed by APExBIO, is a rigorously validated, highly selective IKK inhibitor suitable for dissecting NF-κB-dependent mechanisms in inflammation, apoptosis, and cancer biology. Its robust performance in both in vitro and animal models, combined with high solubility and pathway specificity, positions it as a standard reagent for mechanistic and translational studies. Ongoing research integrating RIPK1, PPP1R3G/PP1γ, and IKK/NF-κB crosstalk will further clarify the compound’s utility in precise pathway modulation (Du et al., 2021).

For ordering and technical documentation, visit the product page for BMS-345541 hydrochloride.